Current Status of Endoscopic Sleeve Gastroplasty: An Opinion Review

Overview

Journal World J Gastroenterol

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2020 Apr 2

PMID 32231416

Citations 4

Authors

Jiunn-Wei Wang

Chih-Yen Chen

Affiliations

Soon will be listed here.

Abstract

Bariatric surgeries have been demonstrated to be safe and effective treatment options for morbid obesity patients, but operative risks and high health care costs limit their clinical application. Endoscopic bariatric therapies are emerging as valuable alternatives for patients with doubts about bariatric surgery or ineligible for it. Endoscopic sleeve gastroplasty (ESG), a relatively novel technique of endoscopic bariatric therapies, has gained standing in the past few years. The safety, feasibility, repeatability, and potential for reversibility of ESG have been proven by multicenter studies. Compared to other weight loss strategies, current evidence demonstrates that ESG offers satisfactory efficacy in weight loss. Even though it is inferior to laparoscopic sleeve gastrectomy, it has lower risks of adverse events than surgical interventions and intragastric balloon within one-year follow-up. Furthermore, ESG may be the ideal weight control strategy for patients who have poor adherence to behavioral interventions. Even so, trends in decreased weight loss effect over time, post-procedure weight regain, post-procedure gut hormone alteration, and possible effects of race and ethnicity on ESG still remain undetermined due to very limited reports and very short follow-ups. Further clinical trials are required to validate and answer these questions.

Citing Articles

Outcomes of concomitant antiobesity medication use with endoscopic sleeve gastroplasty in clinical US settings.

Gala K, Ghusn W, Brunaldi V, McGowan C, Sharaiha R, Maselli D Obes Pillars. 2024; 11:100112.

PMID: 38831924 PMC: 11145356. DOI: 10.1016/j.obpill.2024.100112.

Endoscopic Sleeve Gastroplasty (ESG) Versus Laparoscopic Sleeve Gastroplasty (LSG): A Comparative Review.

Nduma B, Mofor K, Tatang J, Amougou L, Nkeonye S, Chineme P Cureus. 2023; 15(7):e41466.

PMID: 37426405 PMC: 10325692. DOI: 10.7759/cureus.41466.

Endoscopic therapy of weight regain after bariatric surgery.

Bulajic M, di Prampero S, Boskoski I, Costamagna G World J Gastrointest Surg. 2022; 13(12):1584-1596.

PMID: 35070065 PMC: 8727177. DOI: 10.4240/wjgs.v13.i12.1584.

Global trends in research related to sleeve gastrectomy: A bibliometric and visualized study.

Barqawi A, Abushamma F, Akkawi M, Al-Jabi S, Shahwan M, Jairoun A World J Gastrointest Surg. 2021; 13(11):1509-1522.

PMID: 34950437 PMC: 8649568. DOI: 10.4240/wjgs.v13.i11.1509.

References

Chen C, Lee W, Asakawa A, Fujitsuka N, Chong K, Chen S . Insulin secretion and interleukin-1β dependent mechanisms in human diabetes remission after metabolic surgery. Curr Med Chem. 2013; 20(18):2374-88. DOI: 10.2174/0929867311320180008. View

Lee W, Chen C, Chong K, Lee Y, Chen S, Lee S . Changes in postprandial gut hormones after metabolic surgery: a comparison of gastric bypass and sleeve gastrectomy. Surg Obes Relat Dis. 2011; 7(6):683-90. DOI: 10.1016/j.soard.2011.07.009. View

Abu Dayyeh B, Rajan E, Gostout C . Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013; 78(3):530-5. DOI: 10.1016/j.gie.2013.04.197. View

Chen Y, Inui A, Chang E, Chen S, Lee W, Chen C . Comparison of gut hormones and adipokines stimulated by glucagon test among patients with type II diabetes mellitus after metabolic surgery. Neuropeptides. 2015; 55:39-45. DOI: 10.1016/j.npep.2015.11.002. View

Abu Dayyeh B, Kumar N, Edmundowicz S, Jonnalagadda S, Larsen M, Sullivan S . ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015; 82(3):425-38.e5. DOI: 10.1016/j.gie.2015.03.1964. View

Lopez-Nava G, Sharaiha R, Vargas E, Bazerbachi F, Manoel G, Bautista-Castano I . Endoscopic Sleeve Gastroplasty for Obesity: a Multicenter Study of 248 Patients with 24 Months Follow-Up. Obes Surg. 2017; 27(10):2649-2655. DOI: 10.1007/s11695-017-2693-7. View

Dombrowski S, Knittle K, Avenell A, Araujo-Soares V, Sniehotta F . Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials. BMJ. 2014; 348:g2646. PMC: 4020585. DOI: 10.1136/bmj.g2646. View

Lopez-Nava G, Galvao M, da Bautista-Castano I, Jimenez A, de Grado T, Fernandez-Corbelle J . Endoscopic sleeve gastroplasty for the treatment of obesity. Endoscopy. 2014; 47(5):449-52. DOI: 10.1055/s-0034-1390766. View

Chen C, Tsai C . From endocrine to rheumatism: do gut hormones play roles in rheumatoid arthritis?. Rheumatology (Oxford). 2013; 53(2):205-12. DOI: 10.1093/rheumatology/ket255. View

10.

Huang H, Yeh C, Chen J, Lee T, Chen S, Lee W . Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus?. PeerJ. 2018; 6:e4884. PMC: 6003398. DOI: 10.7717/peerj.4884. View

11.

Hill C, Khashab M, Kalloo A, Kumbhari V . Endoluminal weight loss and metabolic therapies: current and future techniques. Ann N Y Acad Sci. 2017; 1411(1):36-52. DOI: 10.1111/nyas.13441. View

12.

Cheskin L, Hill C, Adam A, Fayad L, Dunlap M, Badurdeen D . Endoscopic sleeve gastroplasty versus high-intensity diet and lifestyle therapy: a case-matched study. Gastrointest Endosc. 2019; 91(2):342-349.e1. DOI: 10.1016/j.gie.2019.09.029. View

13.

. Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health. Obes Res. 1998; 6 Suppl 2:51S-209S. View

14.

Fayad L, Adam A, Schweitzer M, Cheskin L, Ajayi T, Dunlap M . Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc. 2018; 89(4):782-788. DOI: 10.1016/j.gie.2018.08.030. View

15.

Flegal K, Kit B, Orpana H, Graubard B . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA. 2013; 309(1):71-82. PMC: 4855514. DOI: 10.1001/jama.2012.113905. View

16.

Huang H, Lee W, Chen S, Chen T, Lee S, Chen C . Bile Acid and Fibroblast Growth Factor 19 Regulation in Obese Diabetics, and Non-Alcoholic Fatty Liver Disease after Sleeve Gastrectomy. J Clin Med. 2019; 8(6). PMC: 6616896. DOI: 10.3390/jcm8060815. View

17.

Lee W, Chen C, Ser K, Chong K, Chen S, Lee P . Differential influences of gastric bypass and sleeve gastrectomy on plasma nesfatin-1 and obestatin levels in patients with type 2 diabetes mellitus. Curr Pharm Des. 2013; 19(32):5830-5. DOI: 10.2174/13816128113198880010. View

18.

Fayad L, Cheskin L, Adam A, Badurdeen D, Hill C, Agnihotri A . Endoscopic sleeve gastroplasty versus intragastric balloon insertion: efficacy, durability, and safety. Endoscopy. 2019; 51(6):532-539. DOI: 10.1055/a-0852-3441. View

19.

Welbourn R, Pournaras D, Dixon J, Higa K, Kinsman R, Ottosson J . Bariatric Surgery Worldwide: Baseline Demographic Description and One-Year Outcomes from the Second IFSO Global Registry Report 2013-2015. Obes Surg. 2017; 28(2):313-322. DOI: 10.1007/s11695-017-2845-9. View

20.

Fiorillo C, Quero G, Vix M, Guerriero L, Pizzicannella M, Lapergola A . 6-Month Gastrointestinal Quality of Life (QoL) Results after Endoscopic Sleeve Gastroplasty and Laparoscopic Sleeve Gastrectomy: A Propensity Score Analysis. Obes Surg. 2020; 30(5):1944-1951. DOI: 10.1007/s11695-020-04419-1. View